Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07280676 · ClinicalTrials.gov registry record · NA
The Effect of Cosmetic Formulations on the Appearance of Grey Hair.
A NA study of Hair Graying, sponsored by Unilever R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 380
- Enrollment target
- 1
- Study location
NCT07280676: Recruiting NA study of Hair Graying, sponsored by Unilever R&D.
NCT07280676 is a NA study of Hair Graying that is actively recruiting participants, run by Unilever R&D. The registered enrollment target is 380 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07280676, a NA study of Hair Graying, is actively recruiting participants, sponsored by Unilever R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 380 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a 6-month (180 days) single-center, double blind study designed to explore the effect of two cosmetic products on the appearance of gray hair.
Primary Outcome
Percent gray hair assessed over the whole head by expert assessor
Conditions Studied
Interventions
- OTHER U82
- OTHER Z63
Study Locations (1)
Minnesota
- Comprehensive Research Group, Inc. - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2025-12-15 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT07280676 shows while recruiting
NCT07280676 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Hair Graying appearing as the primary indexed condition, and to 2 interventions - of which U82 is the first listed.
NCT07280676 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07280676 about?
NCT07280676 is a clinical study titled "The Effect of Cosmetic Formulations on the Appearance of Grey Hair.". This study is a 6-month (180 days) single-center, double blind study designed to explore the effect of two cosmetic products on the appearance of gray hair.
What is the current status of trial NCT07280676?
This trial is currently recruiting. It is a NA study. The enrollment target is 380 participants. The study started on 2025-12-15. Estimated completion is 2026-10.
What conditions does trial NCT07280676 study?
This clinical trial studies the following conditions: Hair Graying.
What interventions are being tested in trial NCT07280676?
The interventions under investigation include: U82 (OTHER), Z63 (OTHER).
Who is sponsoring clinical trial NCT07280676?
This trial is sponsored by Unilever R&D, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07280676 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07280676's enrollment target sits among peer trials
380 273rd of 2000 higher than 1,727 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI